Stenting of Renal Artery Stenosis in Coronary Artery Disease Study

• Status: Unknown status
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The Stenting of Renal Artery Stenosis in Coronary Artery Disease (RASCAD) study is a randomized controlled trial designed to evaluate the effect of renal artery stenting+medical therapy versus medical therapy alone on left ventricular mass progression and cardiovascular morbidity and mortality in patients affected by coronary artery disease and renal artery stenosis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
• Collaborator: Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

Criteria

Inclusion Criteria:

• ischemic heart disease

• angiographic diagnosis of atherosclerotic RAS >50% and ≤80%

Exclusion Criteria:

• Atherosclerotic RAS>80%

• RAS secondary to fibromuscular dysplasia

• AMI

• single functioning kidney and/or sCr >4 mg/dl

• severe aortic valve stenosis

• aortic aneurism necessitating surgery